Home LiteratureArticle Details
PMID: 12524457 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

CTCF functions as a critical regulator of cell-cycle arrest and death after ligation of the B cell receptor on immature B cells.

Qi CF, Martensson A, Mattioli M, Dalla-Favera R, Lobanenkov VV, Morse HC

Abstract

The WEHI 231 B cell lymphoma is used as a model of self-tolerance by clonal deletion because B cell receptor (BCR) ligation results in apoptosis. Two critical events precede cell death: an early rise and fall in expression of MYC and cell-cycle arrest associated with enhanced expression of p21, p27, and p53. CTCF is a transcription factor identified as a repressor of MYC recently shown to cause cell growth inhibition. The present studies demonstrate that BCR ligation of WEHI 231 as well as of normal immature B cells greatly increased expression of CTCF in association with down-regulation of MYC followed by growth arrest and cell death. Conditional expression of CTCF in WEHI 231 mimicked BCR ligation with activated cells showing repressed expression of MYC, enhanced expression of p27, p21, p53, and p19(ARF), and inhibition of cell growth and induction of apoptosis. In keeping with a central role for CTCF in control of B cell death, conditional expression of a CTCF antisense construct in WEHI 231 resulted in inhibition of p27, p21, p53, and p19(ARF) in association with enhanced expression of MYC. Activation of the endogenous CTCF locus by BCR ligation was also mimicked by three other routes to apoptotic death in WEHI 231: inhibition of the phosphoinositide 3-kinase or mTORFRAP signaling cascades and treatment with transforming growth factor (TGF)-beta. Rapid activation of CTCF by BCR ligation or treatment with TGF-beta was suppressed by ligation of CD40. These results demonstrate that CTCF is a common determinant to different pathways of death signaling in immature B cells.

MeSH Terms
Apoptosis B-Lymphocytes/physiology CCCTC-Binding Factor Cell Cycle Cyclin-Dependent Kinase Inhibitor p16 Cyclin-Dependent Kinase Inhibitor p21 Cyclins/physiology DNA-Binding Proteins/physiology Humans Proto-Oncogene Proteins c-myc/physiology Receptors, Antigen, B-Cell/physiology Repressor Proteins Transcription Factors/physiology Transforming Growth Factor beta/physiology Tumor Cells, Cultured Tumor Suppressor Protein p14ARF/physiology Tumor Suppressor Protein p53/physiology
Chemicals
CCCTC-Binding Factor CDKN1A protein, human CTCF protein, human Cdkn2a protein, mouse Ctcf protein, mouse Cyclin-Dependent Kinase Inhibitor p16 Cyclin-Dependent Kinase Inhibitor p21 Cyclins DNA-Binding Proteins Proto-Oncogene Proteins c-myc Receptors, Antigen, B-Cell Repressor Proteins Transcription Factors Transforming Growth Factor beta Tumor Suppressor Protein p14ARF Tumor Suppressor Protein p53
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Qi Chen-Feng
Laboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Martensson Annica
Mattioli Michela
Dalla-Favera Riccardo
Lobanenkov Victor V
Morse Herbert C
References (39)
39 references, click to expand
  1. IPTG-inducible episomal expression system for exogenous genes in primate cells.
    Biotechniques. 2000 Mar;28(3):577-81 PMID: 10723574
  2. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene.
    Nature. 2000 May 25;405(6785):482-5 PMID: 10839546
  3. Functional association of CTCF with the insulator upstream of the H19 gene is parent of origin-specific and methylation-sensitive.
    Curr Biol. 2000 Jul 13;10(14):853-6 PMID: 10899010
  4. Genomic organisation and expression of BCL6 in murine B-cell lymphomas.
    Leuk Res. 2000 Aug;24(8):719-32 PMID: 10936424
  5. Role of phosphatidylinositol 3-kinase in anti-IgM- and anti-IgD-induced apoptosis in B cell lymphomas.
    J Immunol. 2001 Feb 1;166(3):1618-26 PMID: 11160203
  6. Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program.
    Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):992-9 PMID: 11158583
  7. PTEN: life as a tumor suppressor.
    Exp Cell Res. 2001 Mar 10;264(1):29-41 PMID: 11237521
  8. Functional phosphorylation sites in the C-terminal region of the multivalent multifunctional transcriptional factor CTCF.
    Mol Cell Biol. 2001 Mar;21(6):2221-34 PMID: 11238955
  9. Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc.
    Oncogene. 2001 Mar 29;20(14):1688-702 PMID: 11313917
  10. Cell growth inhibition by the multifunctional multivalent zinc-finger factor CTCF.
    Cancer Res. 2001 Aug 15;61(16):6002-7 PMID: 11507042
  11. CTCF is a uniquely versatile transcription regulator linked to epigenetics and disease.
    Trends Genet. 2001 Sep;17(9):520-7 PMID: 11525835
  12. Cooperation of multiple signaling pathways in CD40-regulated gene expression in B lymphocytes.
    Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1497-502 PMID: 11830667
  13. The regulation of growth and differentiation of a murine B cell lymphoma. II. The inhibition of WEHI 231 by anti-immunoglobulin antibodies.
    J Immunol. 1981 Jun;126(6):2466-9 PMID: 6785356
  14. Clonal anergy: the universally anergic B lymphocyte.
    Proc Natl Acad Sci U S A. 1982 Mar;79(6):2013-7 PMID: 6804951
  15. Specific regulation of c-myc oncogene expression in a murine B-cell lymphoma.
    Proc Natl Acad Sci U S A. 1984 Sep;81(17):5546-50 PMID: 6206500
  16. Lymphoma models for B cell activation and tolerance. IV. Growth inhibition by anti-Ig of CH31 and CH33 B lymphoma cells.
    Eur J Immunol. 1986 Dec;16(12):1577-81 PMID: 3493148
  17. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice.
    Nature. 1988 Aug 25;334(6184):676-82 PMID: 3261841
  18. Anti-immunoglobulins induce death by apoptosis in WEHI-231 B lymphoma cells.
    Eur J Immunol. 1990 Jun;20(6):1405-7 PMID: 2369921
  19. Anti-immunoglobulin antibodies induce apoptosis in immature B cell lymphomas.
    Eur J Immunol. 1990 Aug;20(8):1685-90 PMID: 2209683
  20. A novel sequence-specific DNA binding protein which interacts with three regularly spaced direct repeats of the CCCTC-motif in the 5'-flanking sequence of the chicken c-myc gene.
    Oncogene. 1990 Dec;5(12):1743-53 PMID: 2284094
  21. Receptor editing in self-reactive bone marrow B cells.
    J Exp Med. 1993 Apr 1;177(4):1009-20 PMID: 8459201
  22. Receptor editing: an approach by autoreactive B cells to escape tolerance.
    J Exp Med. 1993 Apr 1;177(4):999-1008 PMID: 8459227
  23. WAF1, a potential mediator of p53 tumor suppression.
    Cell. 1993 Nov 19;75(4):817-25 PMID: 8242752
  24. Lymphoma models for B cell activation and tolerance. X. Anti-mu-mediated growth arrest and apoptosis of murine B cell lymphomas is prevented by the stabilization of myc.
    J Exp Med. 1994 Jan 1;179(1):221-8 PMID: 8270867
  25. Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line.
    J Exp Med. 1995 Mar 1;181(3):1169-77 PMID: 7869034
  26. An exceptionally conserved transcriptional repressor, CTCF, employs different combinations of zinc fingers to bind diverged promoter sequences of avian and mammalian c-myc oncogenes.
    Mol Cell Biol. 1996 Jun;16(6):2802-13 PMID: 8649389
  27. Role of cyclin A and p27 in anti-IgM induced G1 growth arrest of murine B-cell lymphomas.
    Mol Biol Cell. 1996 Apr;7(4):553-64 PMID: 8730099
  28. TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells: transcriptional activation of I kappa B alpha.
    Immunity. 1996 Jul;5(1):31-40 PMID: 8758892
  29. p53, the cellular gatekeeper for growth and division.
    Cell. 1997 Feb 7;88(3):323-31 PMID: 9039259
  30. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53.
    Cell. 1998 Mar 20;92(6):713-23 PMID: 9529248
  31. Roles of the tumor suppressor p53 and the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in receptor-mediated apoptosis of WEHI 231 B lymphoma cells.
    J Exp Med. 1998 May 18;187(10):1671-9 PMID: 9584145
  32. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2.
    Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8292-7 PMID: 9653180
  33. Translational induction of the c-myc oncogene via activation of the FRAP/TOR signalling pathway.
    Oncogene. 1998 Aug 13;17(6):769-80 PMID: 9715279
  34. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.
    EMBO J. 1998 Sep 1;17(17):5001-14 PMID: 9724636
  35. Tumor surveillance via the ARF-p53 pathway.
    Genes Dev. 1998 Oct 1;12(19):2984-91 PMID: 9765200
  36. Antigens varying in affinity for the B cell receptor induce differential B lymphocyte responses.
    J Exp Med. 1998 Oct 19;188(8):1453-64 PMID: 9782122
  37. Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC.
    Science. 1999 Jan 29;283(5402):676-9 PMID: 9924025
  38. Differential effects of the widely expressed dMax splice variant of Max on E-box vs initiator element-mediated regulation by c-Myc.
    Oncogene. 1999 Apr 15;18(15):2489-98 PMID: 10229200
  39. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus.
    Nature. 2000 May 25;405(6785):486-9 PMID: 10839547
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2003-01-21
Epub
2003-00-10
Pages
633-8
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC141048
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com